EVH SEC Filings: 8-K, 10-Q, S-3 & 424B – Evolent Health

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 5, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 6, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 7, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Feb 24, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 6, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 11, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Evolent Announces Third Quarter 2026 Results and Reaffirms Full Year Guidance

Nov 5, 2026

8-K

Evolent Health Announces Second Quarter 2026 Financial Results and Raises Full Year Revenue Guidance

Aug 6, 2026

8-K

Evolent Health, Inc. Announces Results of 2026 Annual Meeting of Stockholders

Jun 4, 2026

8-K

Evolent Health Announces First Quarter 2026 Financial Results

May 7, 2026

8-K

Evolent Announces Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook

Feb 24, 2026

8-K

Evolent Health completes stock purchase agreement transactions with Privia Management Company, LLC

Dec 8, 2025

Prospectus

TYPE

HEADLINE

FILED AT

424B7

Description of Class A Common Stock

Nov 3, 2023

424B7

Description of Class A Common Stock

Nov 3, 2023

424B7

Common Stock Owned

Aug 3, 2022

424B7

1,084,001 shares

Feb 18, 2020

424B7

1,577,841 shares

May 28, 2019

424B5

8,816,120 shares

Aug 10, 2017

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jun 10, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jan 2, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jun 10, 2025

S-3ASR

SHELF

Feb 23, 2024

S-8

Registration

Nov 2, 2023

Form D - Notice of Exempt Offering of Securities - Item 06b

May 26, 2023

Proxies

TYPE

HEADLINE

FILED AT

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 24, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 24, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 25, 2025

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 25, 2025

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 26, 2024

DEF 14A

Form DEF 14A - Other definitive proxy statements

Apr 26, 2024

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G/A

MORGAN STANLEY (Filed by)

Sep 8, 2026

McCarthy Daniel Joseph (Reporting)

Aug 28, 2026

144

Form 144 - Report of proposed sale of securities

Aug 26, 2026

SCHEDULE 13G

BlackRock Portfolio Management LLC (Filed by)

Jul 17, 2026

Blackley Seth (Reporting)

Jul 6, 2026

Weinberg Jonathan (Reporting)

Jul 6, 2026

Other

TYPE

HEADLINE

FILED AT

LETTER

Form UPLOAD - SEC-generated letter

Nov 20, 2024

CORRESP

Form CORRESP - Correspondence

Oct 17, 2024

CORRESP

Form CORRESP - Correspondence

Oct 4, 2024

LETTER

Form UPLOAD - SEC-generated letter

Sep 20, 2024

LETTER

Form UPLOAD - SEC-generated letter

Jul 12, 2023

CORRESP

Form CORRESP - Correspondence

Jul 5, 2023

Evolent Health, Inc. EVH · SEC Filings